- $2.84bn
- $3.50bn
- $1.79bn
- 81
- 89
- 88
- 98
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,563 | 867 | 809 | 1,331 | 1,792 |
Cost of Revenue | |||||
Gross Profit | 1,449 | 784 | 715 | 1,206 | 1,689 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,218 | 2,332 | 619 | 788 | 817 |
Operating Profit | -1,655 | -1,465 | 190 | 543 | 975 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2,010 | -1,618 | 130 | 495 | 946 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2,002 | -1,625 | 138 | 495 | 1,471 |
Net Income Before Extraordinary Items | |||||
Net Income | -2,002 | -1,625 | 138 | 495 | 1,471 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -2,002 | -1,625 | 134 | 413 | 1,256 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -4.4 | -4.1 | 2.43 | 20.3 | 66.6 |